Background: Appreciable findings have pointed out pivotal roles of -methyladenosine (mA) machinery in cancer onset and progression. However, limited efforts have been directed towards relevant research in the prostate cancer area.
Methods: A PubMed search was conducted to acquire components of the mRNA mA machinery.